vs
Side-by-side financial comparison of Axon Enterprise (AXON) and Organon & Co. (OGN). Click either name above to swap in a different company.
Organon & Co. is the larger business by last-quarter revenue ($1.5B vs $796.7M, roughly 1.9× Axon Enterprise). Axon Enterprise runs the higher net margin — 0.3% vs -13.6%, a 13.9% gap on every dollar of revenue. On growth, Axon Enterprise posted the faster year-over-year revenue change (38.9% vs -5.3%). Axon Enterprise produced more free cash flow last quarter ($155.4M vs $96.0M). Over the past eight quarters, Axon Enterprise's revenue compounded faster (31.5% CAGR vs -3.6%).
Axon Enterprise, Inc. is an American company based in Scottsdale, Arizona, that develops weapons and technology products for military, law enforcement, and civilians.
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
AXON vs OGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $796.7M | $1.5B |
| Net Profit | $2.7M | $-205.0M |
| Gross Margin | 57.9% | 49.2% |
| Operating Margin | -6.3% | -9.8% |
| Net Margin | 0.3% | -13.6% |
| Revenue YoY | 38.9% | -5.3% |
| Net Profit YoY | -98.0% | -288.1% |
| EPS (diluted) | $0.02 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $796.7M | $1.5B | ||
| Q3 25 | $710.6M | $1.6B | ||
| Q2 25 | $668.5M | $1.6B | ||
| Q1 25 | $603.6M | $1.5B | ||
| Q4 24 | $573.4M | $1.6B | ||
| Q3 24 | $544.3M | $1.6B | ||
| Q2 24 | $504.1M | $1.6B | ||
| Q1 24 | $460.7M | $1.6B |
| Q4 25 | $2.7M | $-205.0M | ||
| Q3 25 | $-2.2M | $160.0M | ||
| Q2 25 | $36.1M | $145.0M | ||
| Q1 25 | $88.0M | $87.0M | ||
| Q4 24 | $136.0M | $109.0M | ||
| Q3 24 | $67.0M | $359.0M | ||
| Q2 24 | $40.8M | $195.0M | ||
| Q1 24 | $133.2M | $201.0M |
| Q4 25 | 57.9% | 49.2% | ||
| Q3 25 | 60.1% | 53.5% | ||
| Q2 25 | 60.4% | 54.8% | ||
| Q1 25 | 60.6% | 55.6% | ||
| Q4 24 | 60.5% | 56.3% | ||
| Q3 24 | 60.8% | 58.3% | ||
| Q2 24 | 60.3% | 58.4% | ||
| Q1 24 | 56.4% | 59.0% |
| Q4 25 | -6.3% | -9.8% | ||
| Q3 25 | -0.3% | 15.2% | ||
| Q2 25 | -0.2% | 14.4% | ||
| Q1 25 | -1.5% | 6.7% | ||
| Q4 24 | -2.6% | 8.1% | ||
| Q3 24 | 4.4% | 13.1% | ||
| Q2 24 | 6.5% | 14.6% | ||
| Q1 24 | 3.5% | 14.5% |
| Q4 25 | 0.3% | -13.6% | ||
| Q3 25 | -0.3% | 10.0% | ||
| Q2 25 | 5.4% | 9.1% | ||
| Q1 25 | 14.6% | 5.8% | ||
| Q4 24 | 23.7% | 6.8% | ||
| Q3 24 | 12.3% | 22.7% | ||
| Q2 24 | 8.1% | 12.1% | ||
| Q1 24 | 28.9% | 12.4% |
| Q4 25 | $0.02 | $-0.78 | ||
| Q3 25 | $-0.03 | $0.61 | ||
| Q2 25 | $0.44 | $0.56 | ||
| Q1 25 | $1.08 | $0.33 | ||
| Q4 24 | $1.68 | $0.42 | ||
| Q3 24 | $0.86 | $1.38 | ||
| Q2 24 | $0.53 | $0.75 | ||
| Q1 24 | $1.73 | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | $574.0M |
| Total DebtLower is stronger | $1.8B | $8.6B |
| Stockholders' EquityBook value | $3.2B | $752.0M |
| Total Assets | $7.0B | $12.9B |
| Debt / EquityLower = less leverage | 0.56× | 11.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $574.0M | ||
| Q3 25 | $2.4B | $672.0M | ||
| Q2 25 | $2.1B | $599.0M | ||
| Q1 25 | $2.2B | $547.0M | ||
| Q4 24 | $788.1M | $675.0M | ||
| Q3 24 | $1.0B | $763.0M | ||
| Q2 24 | $968.9M | $704.0M | ||
| Q1 24 | $964.1M | $575.0M |
| Q4 25 | $1.8B | $8.6B | ||
| Q3 25 | $2.0B | $8.8B | ||
| Q2 25 | $2.0B | $8.9B | ||
| Q1 25 | $2.0B | $9.0B | ||
| Q4 24 | $680.3M | $8.9B | ||
| Q3 24 | — | $8.7B | ||
| Q2 24 | — | $8.7B | ||
| Q1 24 | — | $8.7B |
| Q4 25 | $3.2B | $752.0M | ||
| Q3 25 | $3.0B | $906.0M | ||
| Q2 25 | $2.7B | $733.0M | ||
| Q1 25 | $2.6B | $542.0M | ||
| Q4 24 | $2.3B | $472.0M | ||
| Q3 24 | $2.1B | $493.0M | ||
| Q2 24 | $1.9B | $144.0M | ||
| Q1 24 | $1.8B | $48.0M |
| Q4 25 | $7.0B | $12.9B | ||
| Q3 25 | $6.7B | $13.6B | ||
| Q2 25 | $6.2B | $13.5B | ||
| Q1 25 | $6.1B | $13.2B | ||
| Q4 24 | $4.5B | $13.1B | ||
| Q3 24 | $4.0B | $12.8B | ||
| Q2 24 | $3.7B | $12.2B | ||
| Q1 24 | $3.6B | $11.9B |
| Q4 25 | 0.56× | 11.49× | ||
| Q3 25 | 0.66× | 9.74× | ||
| Q2 25 | 0.73× | 12.14× | ||
| Q1 25 | 0.79× | 16.52× | ||
| Q4 24 | 0.29× | 18.81× | ||
| Q3 24 | — | 17.75× | ||
| Q2 24 | — | 60.11× | ||
| Q1 24 | — | 181.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $217.2M | $141.0M |
| Free Cash FlowOCF − Capex | $155.4M | $96.0M |
| FCF MarginFCF / Revenue | 19.5% | 6.4% |
| Capex IntensityCapex / Revenue | 7.8% | 3.0% |
| Cash ConversionOCF / Net Profit | 79.14× | — |
| TTM Free Cash FlowTrailing 4 quarters | $75.1M | $538.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $217.2M | $141.0M | ||
| Q3 25 | $60.0M | $264.0M | ||
| Q2 25 | $-91.7M | $220.0M | ||
| Q1 25 | $25.8M | $75.0M | ||
| Q4 24 | $250.2M | $390.0M | ||
| Q3 24 | $91.3M | $141.0M | ||
| Q2 24 | $82.8M | $332.0M | ||
| Q1 24 | $-15.9M | $76.0M |
| Q4 25 | $155.4M | $96.0M | ||
| Q3 25 | $33.4M | $218.0M | ||
| Q2 25 | $-114.7M | $181.0M | ||
| Q1 25 | $932.0K | $43.0M | ||
| Q4 24 | $225.4M | $335.0M | ||
| Q3 24 | $64.8M | $99.0M | ||
| Q2 24 | $71.4M | $300.0M | ||
| Q1 24 | $-32.1M | $30.0M |
| Q4 25 | 19.5% | 6.4% | ||
| Q3 25 | 4.7% | 13.6% | ||
| Q2 25 | -17.2% | 11.4% | ||
| Q1 25 | 0.2% | 2.8% | ||
| Q4 24 | 39.3% | 21.0% | ||
| Q3 24 | 11.9% | 6.3% | ||
| Q2 24 | 14.2% | 18.7% | ||
| Q1 24 | -7.0% | 1.8% |
| Q4 25 | 7.8% | 3.0% | ||
| Q3 25 | 3.7% | 2.9% | ||
| Q2 25 | 3.4% | 2.4% | ||
| Q1 25 | 4.1% | 2.1% | ||
| Q4 24 | 4.3% | 3.5% | ||
| Q3 24 | 4.9% | 2.7% | ||
| Q2 24 | 2.2% | 2.0% | ||
| Q1 24 | 3.5% | 2.8% |
| Q4 25 | 79.14× | — | ||
| Q3 25 | — | 1.65× | ||
| Q2 25 | -2.54× | 1.52× | ||
| Q1 25 | 0.29× | 0.86× | ||
| Q4 24 | 1.84× | 3.58× | ||
| Q3 24 | 1.36× | 0.39× | ||
| Q2 24 | 2.03× | 1.70× | ||
| Q1 24 | -0.12× | 0.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXON
| Software And Sensors Segment | $342.5M | 43% |
| TASER Devices Professional | $264.2M | 33% |
| Personal Sensors | $109.1M | 14% |
| Platform Solutions | $80.9M | 10% |
OGN
Segment breakdown not available.
